Haemonetics HAE Hospital — SG&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's hospital — sg&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Haemonetics's hospital — SG&A?
- Haemonetics (HAE) reported hospital — SG&A of $67.03M in Q1 2026.
- How has Haemonetics's hospital — SG&A changed year-over-year?
- Haemonetics's hospital — SG&A increased by 7.0% year-over-year, from $62.63M to $67.03M.
- What is the long-term trend for Haemonetics's hospital — SG&A?
- Over 3 years (2023 to 2026), Haemonetics's hospital — SG&A has grown at a 10.9% compound annual growth rate (CAGR), from $181.37M to $247.25M.
- What does hospital — SG&A mean?
- Represents the total operating expenses incurred by the hospital segment for administrative, marketing, and general overhead functions. This metric reflects the cost of supporting the segment's commercial operations and infrastructure outside of direct production or research activities.